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ABSTRACT
SMOOTH MUSCLE CELL ORGANIZATION IN THE STEM REGION OF THE
GRACILIS COLLATERAL CIRCULATION IN BALB/C MICE
Laura Burckhardt
Of the approximately 8 million Americans who suffer from ischemic peripheral arterial
occlusive disease (PAOD), many present with intermittent claudication, or pain associated
with exercise. Impaired vasodilation of resistance vessels is a potential explanation for this
symptom. Occluded arteries can lead to increased flow through collateral vessels, which
function as natural bypasses around the obstruction. This increase in blood flow and resulting
shear stress can cause outward remodeling, or arteriogenesis, which improves the efficacy of
collaterals. However, following femoral artery ligation in a mouse model of chronic
ischemia, vasodilation in the stem region of collateral vessels is impaired at day 7. In the
outwardly remodeled collateral stem, the vessel diameter increase is not associated with cell
proliferation, suggesting the functionality of the present smooth muscle cells (SMCs) may
account for the impaired vasodilation. A potential mechanism for increased vessel diameter
in the collateral stem is mechanoadaptation of the vascular SMCs to adapt to the increased
fluid shear stress as a result of the increased blood flow. Indeed, decreased SMC overlap and
increased SMC length (indicators of mechanoadaptation) coincides with impaired
vasodilation in the C57BL/6 mouse strain, which exhibits a large number of collateral vessels
and robust collateral remodeling. Collateral density, remodeling following an ischemic event,
and VEGF-A expression differ widely among mouse strains, with BALB/c mice exhibiting
impaired arteriogenesis due to a polymorphism of the Vegfa gene. It is hypothesized that
following femoral artery occlusion in BALB/c mice, the SMC mechanoadaptation in the
profunda femoris artery will be impaired, which should normalize vasodilation, if
mechanoadaptation is a cause of impaired vasodilation in the collateral stem. To test this
hypothesis, the femoral artery was ligated in BALB/c mice, before maximal vasodilation at
day-7 post-surgery. The animals were then perfusion fixed before resecting and
immunostaining the profunda femoris artery to measure SMC length and overlap. The resting
and diameters were not different at 40 ± 3 𝜇m and 48 ± 2 𝜇m, and the maximally dilated
diamters were not different at 61 ± 4 𝜇m, and 65 ± 3 𝜇m for the control and day-7 postligation profunda femoris arteries, respectively. The increase in diameter for day-7 postligation and control profunda femoris arteries were not different, with a percent change of 52
± 11% and 41 ± 3%. SMC length between day-7 post-ligation and control hindlimbs was not
different, at 351 ± 26 𝜇m verses 318 ± 57 𝜇m in the control. SMC overlap reduced in the
day-7 post-ligation hindlimb, 18 ± 2 𝜇m versus 22± 4 𝜇m in the control. These results
indicate a subtle impairment in BALB/c collateral stem remodeling, and suggest that the cell
processes involved in increasing smooth muscle cell length may impair vasodilation
signaling. Further studies are necessary to evaluate the causal relationship between
mechanoadaptive remodeling and impaired vasodilation.
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INTRODUCTION
Peripheral Arterial Occlusive Disease
Peripheral arterial occlusive disease (PAOD) affects approximately eight million
Americans, and has a higher incidence with increased age, high blood pressure, smoking,
high cholesterol, and diabetes [1, 2]. Men and woman are equally affected by PAOD, but
there is a correlation between African-American ethnicity with increased risk [2]. More
common in the lower extremities, PAOD is characterized by the narrowing or blockage
of vessels that carry blood throughout the body, typically caused by a buildup of fatty
plaque in the arteries, or atherosclerosis, Figure 1 [3, 4]. This narrowing or blockage can
lead to ischemia, or inadequate blood flow to maintain normal tissue metabolic function
[5]. Due to this lack of blood supply, the chief symptom of PAOD is intermittent
claudication, or pain in the affected region with physical exertion that is alleviated with
rest [6, 7]. Patients who present with this symptom often concurrently show impaired

Figure 1: Arterial Occlusive Disease Overview. Comparison of blood flow through a
non-atherosclerotic artery verses an atherosclerotic artery [2].
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vasodilation, suggesting they also have a reduced ability to regulate blood flow in nonoccluded vessels [8]. Vasodilation is critical in supporting standard tissue function by
increasing blood flow in response to metabolic needs.
In patients presenting with symptoms of PAOD, there are several tests utilized in
diagnosis. The ankle-brachial index compares ankle blood pressure with arm blood
pressure, with a low index suggesting artery blockage [9]. Ultrasound tests utilize sound
waves to check for blocked or diseased arteries [2]. Magnetic resonance angiography and
computed tomographic angiography utilize a contrast dye injected through an IV, in
conjunction with a MRI or a CT scan, respectively, to visualize the vasculature and
identify areas of concern [7]. Patients with PAOD are at a high risk for developing
coronary artery disease and cerebrovascular disease, which are precursors to myocardial
infarctions and strokes, respectively [2].
Current treatments for PAOD aim to impede the progression of disease by natural,
pharmacologic, or mechanical mechanisms. The first line of therapy is lifestyle changes,
such as cessation of smoking, increased exercise regimens, and diet. Post-lifestyle
changes or in conjunction with, pharmacologic agents such as aspirin or other antiplatelet medications are prescribed to prevent the development of PAOD-associated
complications [6]. For patients in whom these therapies are ineffective, invasive
approaches such as balloon angioplasty with stenting (Figure 2) or surgical bypass are
the next treatment options. Stenting may not be a permanent solution however, as vessels
may restenose, or re-narrow around the stent due to intimal hyperplasia [10]. In addition,
bypass surgery is a high-risk procedure, and even if successful, may need to be revisited
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due to occlusion of the bypass vessel [11]. Due to the sub-optimal performance of current
treatment options, alternative therapies are necessary.

Figure 2: Blood Flow Improvement with Stenting Intervention.
Overview of therapeutic option for PAOD, with blood flow returned to normal
after stenting [12].
Arteriogenesis
Although bypasses around occlusions can be surgically created, there are natural
bypasses that may aid in normalizing blood flow. Initiated by a hemodynamically
relevant stenosis of a main feeding artery, blood is redirected through alternative
collateral vessels [13]. These vessels act as natural bypasses to the stenosis, connecting a
high pressure region to a low-pressure region, thus increasing blood velocity and
associated fluid shear stress through the collaterals, improving prognosis due to delivery
of oxygen to tissue [13]. A mechanism of the vascular growth, arteriogenesis is the
remodeling of preexisting collateral arteries, induced by the increased fluid shear stress
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and characterized by a chronically increased luminal diameter that normalizes the fluid
shear stress [13, 14].
The initial shear stress of the increased blood flow leads to increased monocyte
chemoattractant protein-1 (MCP-1) expression on endothelial cells, and of surface
receptors involved in the tethering, rolling, and migration of monocytes. Following
extravasation, monocytes transform into macrophages and produce numerous cytokines,
growth factors, and enzymes. These agents include matrix-metalloproteinases (MMPs),
which degrade the extracellular matrix to allow for outward enlargement of the vessel
wall, and tumor necrosis factor-α (TNF-α), which is an inflammatory agent that
positively modulates arteriogenesis [15]. VEGF is also secreted, inducing endothelial cell
proliferation [16]. There are three regions in the collateral: the stem, midzone, and
reentry, with the preceding mechanistic explanation most accurately reflecting
arteriogenesis in the midzone. Interestingly, arteriogenesis of the collateral stem may
involve either SMC proliferation, as is traditionally described, or mechanoadaptation,
which is the rearrangement of the SMCs in order to increase vessel diameter [17,18].
Single factor trials for the stimulation of arteriogenesis, such as the addition of Vascular
Endothelial Growth Factor (VEGF) or fibroblast growth factor (FGF), have failed to
show therapeutic benefits [19]. Arteriogenesis may still offer a promising therapeutic
target, although a holistic understanding of the mechanisms involved is crucial for
successful next-generation therapies [13].
Previous Work
SMC mechanoadaptation is characterized by morphological changes in cellular
organization and shape [18]. This modification has been investigated in rat arterioles in
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response to prolonged exposure of norepinephrine (NE), a vasoconstrictor [18].
Arterioles exposed to NE for 4 hours did not return to original resting diameter upon
removal of the NE, due to a significant increase in SMC overlap causing remodeling of
the vascular wall and indicating SMC mechanical reorientation Figure 3 [18]. This
phenomenon may occur due to the mechanisms involved in increasing overlap between

cells utilizing less energy than cellular constriction.
Figure 3: Smooth Muscle Cell Mechanoadaptation in Rat Arterioles. Increase
in SMC overlap in rat arterioles when exposed to the vasoconstrictor norepinephrine for
prolonged periods of time [18].
The profunda femoris artery, the collateral stem of the gracilis collateral
circulation, has an increased resting and maximally dilated diameter on day-7 following
creation of a chronic ischemic model via femoral ligation. This increase was associated
with an increase in blood flow, as well as endothelial and smooth muscle-dependent
vasodilation impairment [20]. As the collateral enlarges, there is a phenotypic change in
SMCs from contractile to synthetic, due to the enhanced proliferative nature of the
synthetic phenotype. With increased counts of synthetic, non-contractile cells, although
SMC numbers increase and the corresponding vessel diameters enlarge, vessel reactivity
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would be impaired [21]. However, there was no difference in the number of SMCs in the
profunda of the day-7 post-ligation hindlimb verses the control hindlimb, suggesting an
alternate factor other than cell proliferation was involved with the observed increased
vessel diameter, such as mechanoadaptation [20]. This was supported with observation of
an increase in SMC length in the day-7 post-ligation hindlimb of C57BL/6 models, and a
decrease in SMC overlap [22].
With this observation applying to C57BL/6 models, it is important to remember
that mouse strains differ widely in collateral density and remodeling following ischemic
events [23]. Collateral and hindpaw perfusion were lower in BALB/c than C57BL/6,
which can be explained by lower collateral density, and BALB/c exhibited greater
hindlimb use impairment when compared to the C57BL/6 models. A potential molecular
explanation for this impairment is reduced TNF-∝ expression, an inflammatory cytokine
that positively modulates arteriogenesis, which was 50% lower in BALB/c mice.
Additionally, a cis-acting polymorphism in the Vegfa gene in BALB/c could contribute to
reduced VEGF-A expression, a growth factor for endothelial cell proliferation, and in
turn decreased collateral density and remodeling [23]. These explanations are more
associated with the classic arteriogenesis seen in the midzone region, and do not
necessarily account for the reorganization of the smooth muscles cells seen in the stem
region. Examination of the differences associated with each strain with regards to
mechanoadaptation has yet to be shown in literature.
Specific Aims of Study
With a high prevalence of peripheral arterial occlusive disease, and sub-optimal
performance of current treatments options, it is clear that alternative therapeutic targets
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need to be established. This begins with a greater understanding of the mechanism of
collateral enlargement, the process in which preexisting collateral arteries outwardly
remodel to form conduit vessels. Following an arterial occlusion, increase in shear stress
induces collaterals to increase in diameter and lose functionality in terms of vasodilation.
The number of SMCs does not increase, suggesting SMC proliferation is not the cause of
outward collateral remodeling. SMC overlap decreases, with longer SMC lengths in
C57BL/6 murine models, suggesting mechanoadaptation of the SMCs. Collateral density,
remodeling following an ischemic event, and VEGF-A expression differ widely among
murine strains, with BALB/c mice showing impaired arteriogenesis potentially due to a
cis-acting polymorphism of the Vegfa gene. With this information in mind, the aims of
this study were to:
1.) Test the hypothesis that a strain of mouse that exhibits impaired mid-zone
arteriogenesis will also exhibit impaired mechanoadaptation, by examining
SMC length and overlap in the stem region of the gracilis collateral circulation
2.) Test the hypothesis that mechanoadaptation impairs vasodilation, by
observing if an inhibited degree of mechanoadaptation results in normalized
vasodilation in response to vasodilatory agents SNP and papaverine
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MATERIALS AND METHODS
Animal Husbandry
Male BALB/c mice were used for all experimental procedures according to the
protocols approved by the Institutional Care and Use Committee (IACUC) of California
Polytechnic State University (Cal Poly). All mice were maintained in a temperature and
12-hour light cycle controlled room in the University Vivarium. Mice were specifically
housed by litter in micro-isolator cages, supplied with feed, water, and enrichment
(houses and tubes), and monitored daily.
Collateral Enlargement Model
A murine collateral enlargement model was created via femoral artery ligation in
the left hindlimb of the animals. Prior to surgery, the surgical bench was disinfected with
70% isopropyl alcohol, and all surgical instruments and materials were sterilized in an
autoclave. After weighing the animal, mice were anesthetized using 1-3% isoflourane gas
at an oxygen flow rate between 0.8-1.2 l⋅min-1, administered through a nose-cone. Hair
on the anterior hindlimb was depilated, and surgical area was disinfected with Nolvasan.
The mice were placed in a supine position on a controlled heated surgical stage, with a
rectal probe monitoring the animal’s core-body temperature. Veterinary ointment was
added to the eyes to avoid corneal desiccation.
A small incision was made on the middle, medial aspect of the left thigh, which
was then extended to the abdominal wall. The subcutaneous connective tissue was blunt
dissected to maximize surgical exposure. Throughout the procedure, the incision site was
irrigated with sterile phosphate buffered saline (PBS) to prevent tissue desiccation. To
expose the ligation site, the epigastric fat pad was reflected medially following blunt
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dissection. The femoral artery was blunt dissected from the neurovascular bundle
downstream from the deep femoral branch. The femoral artery was ligated with 6.0 silk
suture distal to the epigastric branch and proximal to the popliteal branch, Figure 4. The
skin was closed using 7.0 polypropylene suture. For control, the surgical procedure
outlined previously was performed on the contralateral hindlimb, with the exception of
the ligation of the femoral artery. Post-surgery, animals were given a subcutaneous
injection of buprenorphine (0.075mg/kg), and supplied with buprenorphine water (0.01
mg/mL) for 2-3 days.

Figure 4. Overview of Hindlimb Vascular Flow. A) Normal blood flow through hindlimb,
directionally indicated though dotted lines and arrows. B) Indicated site of ligation with resulting
redirection of blood flow through the profunda femoris artery and collateral [21].

Clinical Ambulation Scoring
Following the surgery, animals were observed daily for ambulation, and scored
from 0-3 based on hindpaw range of motion. A dragging hindpaw established a score of
3, no plantar flexion and constant dorsiflexion constituted a score of 2, some planar
flexion a 1, and normal use a 0. Animals were monitored until normal ambulation was
observed on two consecutive days, or until day-7 post-ligation.
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Intravital Microscopy
To analyze the vasodilatory capacity of the collateral stem, vasodilation was
assessed in mice 7-days post-ligation. The surgical area was prepared and mice were
anesthetized as described previously. A small incision was made on the middle, medial
aspect of the left hindlimb, with the incision continued up the abdominal wall. The
subcutaneous connective tissue was blunt dissected to maximize surgical exposure, the
epigastric artery vein pair was cauterized and the epigastric fat pad was removed. The
skin overlying the saphenous artery-vein pair and profunda femoris artery-vein pair was
removed to maximize exposure and improve visibility. PBS was dripped over exposed
tissue, and plastic wrap was placed over area to prevent desiccation, before a 30–minute
equilibration period before vasodilator application, during which time the contralateral
limb was exposed.
An intravital microscope, the Olympus BXFM, with a 5x objective and interface
with QCapture imaging software was utilized to capture images of the profunda femoris
artery at rest and following maximal vasodilation. This dilation was in response to
sodium nitroprusside (SNP, 10-3) and papaverine (10-2), which were applied for 5 minutes
prior to imaging. This procedure was repeated on the contralateral side.
Sample Perfusion and Fixation
In order to ensure cylindrical vascular dimensions were preserved post-resection,
mice were perfusion fixed. Through a thoracotomy, an incision was made in the apex in
the heart into the left ventricle, and a catheter was inserted and secured with a vascular
clamp. A cycle of 10mL PBS, then 5mL 4% paraformaldehyde (PFA), followed by 10ml
PBS was driven through the catheter, with a syringe pump (4 mL/min). During this cycle,
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SNP and papaverine were applied to the superficial areas of the hindlimb, to ensure that
the maximum diameter of the profunda femoris was maintained. Post fixation, the
anterior gracilis muscle and profunda femoris artery were resected and post-fixed in 4%
PFA for approximately 24 hours before being rinsing and storing in PBS at 4°C.
Confocal Microscopy
Confocal microscopy was used to visualize smooth muscle cells around each
artery. Samples were stained with 1:200 1A4 clone (α-smooth muscle actin, Cy3
conjugate) with 0.1% saponin and 2% BSA reconstituted in PBS for 7 days, with 0.3 mL
of solution per sample. Following, they were washed in 0.1% saponin in PBS 3x for 20
minutes at room temperature, and then in PBS for 30 minutes. The samples were then
mounted onto depression slides with 50/50 PBS and Glycerol. Utilizing a confocal
microscope and 40x oil immersion objective, images of the profunda femoris artery were
captured with Fluoview Viewer (FV10-ASW 4.1) software. Image stacks in the z
direction were taken with 1-micron slices to approximately half the diameter for each
artery.
Image Analysis
The intravital microscopy images of the profunda femoris at rest and maximum
dilation were used to measure average diameter of the vessel at those two conditions. The
z-stacks of the profunda femoris, taken with the confocal microscope, were merged into
single, 3-D reconstructions. These images were used to measure average smooth muscle
cell overlap between the individual cells, determined by measuring all of the
distinguishable overlaps between cells on the image, and averaging those values. In
addition, smooth muscle cell length measurements were determined based on a formula
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validated in previous studies [18, 24], utilizing statistical patterns of SMC orientation to
establish average SMC lengths with a single view of the image. This formula requires
several assumptions, as follows:
1.

The vessels studied are fully dilated and cylindrical in shape.

2.

There is only one layer of SMCs surrounding the studied vessel.

3.

The SMCs have 2 end points only.

4.

There are only two visible types of cells: “wrap cells, extending across the
entire visible portion of the vessel, and “taper” cells, partially extending
the visible portion of the vessel.

A 100µm length of artery was delineated for each 3D reconstruction, and average
SMC length for each vessel, Lv, was determined using Equation 1 below [18, 24]:
𝐿! = 4𝜋𝑅! 𝐹(𝑆! + 𝑆! )/𝑇!

(Eq. 1)

In equation 1, Lc is the average SMC length, Rv is the radius of the artery, F is the
fraction of vessel circumference in which measurements were made, Sw is the number of
wrap cells, St is the length of all tapered cells divided by the length of one wrap cell, and
Tv is the number of taper cells.
Statistical Analysis
Independent Student’s t-tests were performed between the data from control and
day-7 post-ligation hindlimbs, as well as the ambulation data between mice strains. A pvalue of less than 0.05 indicated statistical significance.
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RESULTS
The aims of this study were to test the hypothesis of smooth muscle cell
mechanoadaptation impairment in BALB/c mice during outward remodeling of the
collateral stem following an ischemic event, as well as examine if impaired
mechanoadaptation normalized vasodilation. The first objective within these aims was to
investigate functional hindlimb use impairment when compared to C57BL/6 mice, which
possess well-developed collaterals, as quantified by clinical ambulation scoring. The
second objective was to measure the resting and maximally-dilated profunda femoris
artery in vivo to test if collateral enlargement occurred, along with impaired vasodilation
7 days post-ischemic event. The third objective was to test the hypothesis of
mechanoadaptation by determining SMC overlap and length in the profunda.
Clinical Ambulation Scoring
It was expected that BALB/c mice would have greater functional hindlimb
impairment when compared to C57BL/6 mice [22]. The recovery time to normal
hindlimb ambulation trended towards longer in BALB/c mice, with 6 ± 0.4 days, where
C57BL/6 mice required 5 ± 0.3 days, Figure 5.
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Figure 5: Murine Strain Comparison of Days to Normal Ambulation. Average days
to return to normal hindlimb use following ischemic event, as determined by clinical
ambulation scoring.
Functional Vasodilation in the Ischemic Profunda
As poor ambulation results are suggestive of functional impairment, this was next
examined. Both resting and maximally dilated diameters of the profunda femoris artery
on the day-7 post-ligation limbs trended towards greater diameters than the control
hindlimb, although the results were not statistically significant (p > 0.05). The resting
diameters were 40 ± 3 𝜇m and 48 ± 2 𝜇m, and the maximally dilated diameters were 61
± 4 𝜇m 65 ± 3 𝜇m for the control and day-7 post-ligation hindlimbs, respectively. The
increase in diameter for day-7 post-ligation and control limbs were not different, and
represented a percent change of 52 ± 11% and 41 ± 3%, respectively (Figure 6).
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Figure 6: Functional Vasodilation in Ischemic Profunda. A) Representative images of
profunda femoris at resting diameter and B) at maximally dilated diameter in response to
papaverine and SNP C) Average vessel diameter resting and maximally dilated diameters for
control and day-7 post-ligation hindlimbs. D) Percent change in vessel diameter from resting
to maximum dilation, n=7.
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Mechanoadaptation
The absence of impaired vasodilation is suggestive of a lack of remodeling, so
indicators of mechanoadaptation, SMC length and overlap, were examined. The smooth
muscle cells trended towards longer lengths in the day-7 post-ligation hindlimb compared
to the control hindlimb, although the results were not significant (p>0.05), with the
lengths in the control hindlimb of 318 ± 57 𝜇m, and in the day-7 post-ligation hindlimb
of 351 ± 26 𝜇m. An overview of the types of SMCs, wrap and taper, which were used to
calculate SMC lengths can be seen in Figure 7, with the results in Figure 8.

1

2

Figure 7: Confocal Microscopy View of Profunda Femoris Smooth Muscle Cells. 1)
Taper cell partially extends across visible artery portion. 2) Wrap cell extends across
entire visible portion of artery
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Figure 8: Profunda Femoris Artery Smooth Muscle Cell Length. Average SMC
lengths in profunda femoris artery of control and day-7 post-ligation hindlimbs, n=5
control, n=6 day-7.
The average SMC overlap in the control hindlimb was longer than the SMC overlap in
the day-7 post-ligation hindlimb, at 22 ± 4 𝜇m in the control hindlimb and 18 ± 2 𝜇m in
the day-7 post-ligation hindlimb, p<0.05.
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Figure 9: Profunda Femoris Artery Smooth Muscle Cell Overlap. A) Example of
overlap between two SMCs using confocal microscopy at 40x. B) Average SMC overlap
in the profunda femoris artery in the control and day-7 post-ligation hindlimbs, n=5
control, n=6 day-7; p<0.05.
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DISCUSSION
Patients who suffer from peripheral arterial occlusive disease may experience
intermittent claudication, which may be explained by impaired vasodilation. Therefore,
restoring normal vasodilation may reduce associated symptoms, and improve patient
prognosis. In mouse models with robust collateral networks and collateral growth,
impaired vasodilation can be explained by smooth muscle cell dysfunction, presumably
as a result of mechanoadaptation (increased SMC length and decreased SMC overlap) in
the context of collateral enlargement. Therefore, we sought to support the causal role of
mechanoadaptation in impaired vasodilation by evaluating the degree of
mechanoadaptation in an animal model that exhibits reduced arteriogenesis, and the
associated vasodilation.
The first objective of the study was to test the hypothesis that an animal model
that exhibits reduced arteriogenesis results in decreased functional use following an
ischemic event, by examining functional hindlimb use post-femoral artery ligation in
comparison to the C57BL/6. This examination allows for calibration of the work to other
relative investigative groups, as ambulation scoring is a common assessment. The
average amount of days to normal ambulation trended towards higher in BALB/c
compared to C57BL/6. This trend was consistent with previous studies, but significance
was not observed. As BALB/c exhibit fewer pre-existing collaterals and decreased
collateral remodeling, the lack of significance may be due to subjectivity of ambulation
scoring, and the resulting inconsistency between the score assigners.
As ambulation scoring only assesses overall functional use of the hindlimb, the
second more specific aim of the study investigated functional vasodilation in the ischemic
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profunda. Both resting and maximally dilated average diameters of the profunda femoris
trended towards greater than the control hindlimb, suggesting arteriogenesis characterized
by outward remodeling had ensued, although the results were not significant. The percent
change in diameter from resting to maximum dilation was not different in the control and
day-7 post-ligation hindlimbs, suggesting vasodilation was not impaired. If
mechanoadaptation is impaired within BALB/c mice, this finding is consistent with the
hypothesis that mechanoadaption impairs vasodilation.
With normal vasodilation observed in the samples, the final aim of the study was
to examine the presence and degree of mechanoadaptation in the ischemic hindlimb,
characterized by a decrease in SMC overlap and an increased length. There was not an
increase in SMC length in the day-7 post-ligation hindlimb compared to the control
hindlimb, but there was a decrease in SMC overlap. This suggests a subtle form of
mechanoadaptation in the SMCs of the collateral stem of the ischemic profunda, but an
impairment in the degree of remodeling as compared to the C57BL/6 model, potentially
due to lower amounts of TNF-∝ and VEGF-A comparatively seen in this strain [23]. It
would be interesting to examine whether the presence of these two factors would enhance
SMC mechanoadaptation in the BALB/c, which could offer further clarity into a potential
therapeutic target. To establish a necessary and sufficient relationship, TNF-∝ and
VEGF-A could be inhibited in separate experiments, and the degree of
mechanoadaptation in the stem region of the profunda femoris observed.
There were several limitations in this study that may have contributed to
variability in the results. In the formula for SMC length, several assumptions were made.
One assumption was that the vessels were fully dilated and cylindrical in shape, which is
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not entirely feasible even with the precautions of perfusion fixation and the utilization of
a depression slide for imaging. Furthermore, it was assumed that there is only one layer
of SMCs on the vessel, which was not verified. In the comparison of results from the
BALB/c to the C57BL/6 models, the data was compared from two different surgeons.
Differences in technique may have led to variation in the data in which a comparison was
not appropriate.
Overall, there is a promising correlation between impaired vasodilation and
mechanoadaption in varying murine strains. The effect of factors that differ in mice
strains such as VEGF-A expression, TNF-∝ levels, and pre-existing collaterals on
impaired mechanoadaptation need to be established. With further study, the potential
correlation between mechanoadaptation and impaired vasodilation can be prospectively
utilized to establish a causal relationship to help better understand impaired vasodilation
and other factors involving peripheral arterial occlusive disease. A better understanding
of these relationships will hopefully lead to establishing an effective target for future
therapeutics.
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APPENDIX A: Femoral Artery Ligation Protocol
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APPENDIX B: Perfusion Fixation Protocol
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APPENDIX C: ASMA Staining Protocol
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APPENDIX D: Confocal Protocol
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APPENDIX E: Raw Images
In vivo imaging (5x)
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Confocal Images (40x)
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N=2 Profunda Femoris Artery Day-7
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N=3 Profunda Femoris Artery Control
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N=4 Profunda Femoris Artery Control
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